164 related articles for article (PubMed ID: 17591074)
1. Serum hyaluronan and laminin level in children with chronic hepatitis B during long-term lamivudine treatment.
Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
Hepatogastroenterology; 2007; 54(75):834-8. PubMed ID: 17591074
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
Lebensztejn DM; Skiba E; Sobaniec-Łotowska ME; Kaczmarski M
Adv Med Sci; 2007; 52():114-9. PubMed ID: 18217401
[TBL] [Abstract][Full Text] [Related]
3. [The evaluation of hyaluronic acid and laminin concentration in serum in children with chronic hepatitis B treated with lamivudine, unresponsive to previous interferon-alpha therapy].
Skiba E; Lebensztejn DM; Werpachowska I; Kaczmarski M
Pol Merkur Lekarski; 2005 Mar; 18(105):268-70. PubMed ID: 15997629
[TBL] [Abstract][Full Text] [Related]
4. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
5. Serum hyaluronic acid during lamivudine treatment in chronic hepatitis B.
Grzeszczuk A; Prokopowicz D
Rocz Akad Med Bialymst; 2004; 49():275-9. PubMed ID: 15631357
[TBL] [Abstract][Full Text] [Related]
6. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
[TBL] [Abstract][Full Text] [Related]
9. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
11. [Serum gamma-glutamyl transpeptidase activity in children with chronic hepatitis B].
Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
Pol Merkur Lekarski; 2005 Mar; 18(105):271-4. PubMed ID: 15997630
[TBL] [Abstract][Full Text] [Related]
12. Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Kaczmarski M; Sobaniec-Łotowska M; Bauer M; Voelker M; Schuppan D
Hepatology; 2004 Mar; 39(3):868-9. PubMed ID: 14999715
[No Abstract] [Full Text] [Related]
13. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Jonas MM; Little NR; Gardner SD;
J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
[TBL] [Abstract][Full Text] [Related]
14. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
Chen YP; Feng XR; Dai L; Ding HB; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
[TBL] [Abstract][Full Text] [Related]
15. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
Liang XH; Zheng H
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):67-8. PubMed ID: 12575242
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
[TBL] [Abstract][Full Text] [Related]
17. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B.
Zhu CL; Li WT; Li Y; Gao RT
J Dig Dis; 2012 Nov; 13(11):558-63. PubMed ID: 23107442
[TBL] [Abstract][Full Text] [Related]
19. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
20. The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.
Sökücü S; Gökçe S; Güllüoğlu M; Aydoğan A; Celtik C; Durmaz O
Scand J Infect Dis; 2010 Sep; 42(9):699-703. PubMed ID: 20429710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
